Episode 3: Dr Christopher Jones, PharmD, DrPH on telehealth and opioid use disorder and overdose treatment during COVID-19Episode 3: Dr Christopher Jones, PharmD, DrPH on telehealth and opioid use disorder and overdose treatment during COVID-19
Behind the Evidence
Dr. Christopher M. Jones discusses how telehealth has influenced opioid use disorder treatment during COVID-19, highlighting access disparities and policy impacts.
32:09•28 Jun 2023
Telehealth and Opioid Use Disorder: Insights from Dr. Christopher M. Jones
Episode Overview
- The study evaluates the impact of telehealth services and policy changes for opioid use disorder (OUD) during the COVID-19 pandemic
- Dr. Jones discusses disparities in access to OUD telehealth services, emphasizing the importance of equitable healthcare delivery
- Insights into proposed DEA rule changes and impactful research questions that drive policy decisions
- The significance of OUD-related telehealth services for retention in treatment and association with medically treated overdose among Medicare beneficiaries
- Dr. Jones addresses the integration of telehealth into in-person care and the pursuit of equitable healthcare delivery
“Telehealth services for OUD are an important tool in the toolbox. How do we integrate that into in-person care and other services? And how do we also continue to advance telehealth in an equitable way? - Dr. Christopher M. Jones”
What happens when telehealth meets the pressing issue of opioid use disorder? In this episode of 'Behind the Evidence', Dr. Christopher M. Jones, a leading expert from the CDC, shares his findings on how telehealth services have shaped opioid use disorder (OUD) treatment during the COVID-19 pandemic. Hosted by Dr. Honora L. Englander and Dr. Marc R. Larochelle, this conversation digs into the nitty-gritty of Dr. Jones's recent study published in JAMA Psychiatry.
They explore the utilization of telehealth for OUD, retention rates in treatment, and the crucial link to medically treated overdoses among Medicare beneficiaries. One of the standout points is the stark disparities in access to telehealth services for OUD, shedding light on the ongoing struggle for equitable healthcare delivery. Dr. Jones doesn't shy away from discussing the proposed DEA rule changes and their potential impact on future policies.
This episode is a must-listen for anyone interested in the intersection of technology and addiction treatment, offering a deep dive into the challenges and opportunities presented by telehealth in this critical field.
Do you want to link to this podcast?
Get the buttons here!
More From This Show
The latest episodes from the same podcast.
Related Episodes
Similar episodes from other shows in the catalogue.